Last updated 2026-06-18
- Raised $5.2M funding round, Mar 2009
- Raised $4.8M funding round, Feb 2012
- Raised $4M funding round, Jan 2006
Total raised
$14.5M
Last: 2012-02
Stage
Series B
Founded
2003
Headcount
10
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences
About
CorAssist is a clinical-stage medical device company developing therapeutic products for treating heart failure with preserved ejection fraction. The companys proprietary technology enables the implantation of a device that directly improves cardiac diastolic function. CORolla is an elastic, self-expanding, internal, spring-like device implanted inside the left ventricle through a transapical or percutaneous procedure. The device assists diastolic function by improving diastolic dynamics and filling performance, and does not require an external power source. ImCardia, the companys first product, is an elastic, self-expanding device that is attached to the external left ventricular surface through a simple off-pump procedure.
Funding history · 4 rounds · $14.5M total
2012-02
$4.8M
2009-03
2006-01
2004-07
Q&A
- What is CorAssist's current operational status?
- CorAssist is currently inactive, having ceased operations in December 2022.
- What was CorAssist's primary focus?
- CorAssist was a clinical-stage medical device company focused on developing therapeutic products for treating heart failure with preserved ejection fraction.
- What was the total amount of funding raised by CorAssist?
- CorAssist raised a total of $14,500,000 across its funding rounds.
- When was CorAssist's last funding round?
- CorAssist's last funding round occurred in February 2012, raising $4,800,000 from Shareholders.
- Who were the investors in CorAssist's March 2009 funding round?
- In March 2009, CorAssist raised $5,200,000 from investors including Aurum Ventures M.K.I.
- Who are the co-founders of CorAssist?
- The co-founders of CorAssist are Yotam Reisner, Shay Dubi, and Yair Feld.
- What product was CorAssist developing for heart failure treatment?
- CorAssist was developing CORolla, an elastic, self-expanding, internal, spring-like device implanted inside the left ventricle to assist diastolic function, and ImCardia, an elastic, self-expanding device attached to the external left ventricular surface.
Team · 3
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B
Tags
minimally-invasivecardiologymedical-devicestherapeuticsheart-failuresurgerychronic-patientscardiovascularhospitalshealthcare-providersclinics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/151987 |
Identifiers & details
| Founded | 2003-1 |
|---|---|
| Employees (exact) | 10 |
| Status reason | Non Active, Dec 2022 ceased to operate |